MoneyWorks4Me

Sharon Bio-Medicine informs about Outcome of Board Meeting

10 Jun 2015 Evaluate

Sharon Bio-Medicine has informed that the Board of Directors of the Company at its meeting held on June 10, 2015, has approved the allotment of 66,51,300 equity shares of Rs 2 each at a premium of Rs 48 per share to the allottees, upon their exercise of option to convert the convertible warrants into equity shares.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..